View in EDS

Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.

Saved in:
Bibliographic Details
Title: Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
Authors: Deshpande SR; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Podder TK; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio., Grubb W; Department of Radiation Oncology, Medical College of Georgia, Augusta, Georgia., Zhang Y; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio., Zheng Y; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio., Towe C; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Division of Cardiothoracic Surgery, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, Ohio., Linden P; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Division of Cardiothoracic Surgery, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, Ohio., Avril N; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Department of Radiology, Nuclear Medicine, University Hospitals, Cleveland, Ohio., Biswas T; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Source: Advances in radiation oncology [Adv Radiat Oncol] 2023 Jul 09; Vol. 9 (1), pp. 101313. Date of Electronic Publication: 2023 Jul 09 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101677247 Publication Model: eCollection Cited Medium: Print ISSN: 2452-1094 (Print) Linking ISSN: 24521094 NLM ISO Abbreviation: Adv Radiat Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2452-1094
DOI:10.1016/j.adro.2023.101313